These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22163046)

  • 21. The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis.
    Sanders ME; Norcross EW; Robertson ZM; Moore QC; Fratkin J; Marquart ME
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):865-72. PubMed ID: 21051708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacillus endophthalmitis: roles of bacterial toxins and motility during infection.
    Callegan MC; Kane ST; Cochran DC; Novosad B; Gilmore MS; Gominet M; Lereclus D
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3233-8. PubMed ID: 16123424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection assessed in an endophthalmitis model.
    Callegan MC; Jett BD; Hancock LE; Gilmore MS
    Infect Immun; 1999 Jul; 67(7):3357-66. PubMed ID: 10377113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis.
    Talreja D; Kaye KS; Yu FS; Walia SK; Kumar A
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2392-402. PubMed ID: 24644055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disarming Pore-Forming Toxins with Biomimetic Nanosponges in Intraocular Infections.
    Coburn PS; Miller FC; LaGrow AL; Land C; Mursalin H; Livingston E; Amayem O; Chen Y; Gao W; Zhang L; Callegan MC
    mSphere; 2019 May; 4(3):. PubMed ID: 31092603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward improving therapeutic regimens for Bacillus endophthalmitis.
    Wiskur BJ; Robinson ML; Farrand AJ; Novosad BD; Callegan MC
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1480-7. PubMed ID: 18385066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targets of immunomodulation in bacterial endophthalmitis.
    Miller FC; Coburn PS; Huzzatul MM; LaGrow AL; Livingston E; Callegan MC
    Prog Retin Eye Res; 2019 Nov; 73():100763. PubMed ID: 31150824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitis.
    Pollack JS; Beecher DJ; Pulido JS; Lee Wong AC
    Curr Eye Res; 2004; 29(4-5):253-9. PubMed ID: 15590470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The
    Coburn PS; Miller FC; Enty MA; Land C; LaGrow AL; Mursalin MH; Callegan MC
    Microbiology (Reading); 2021 May; 167(5):. PubMed ID: 34032564
    [No Abstract]   [Full Text] [Related]  

  • 30. Toll-like receptor 2 (TLR2) engages endoplasmic reticulum stress sensor IRE1α to regulate retinal innate responses in Staphylococcus aureus endophthalmitis.
    Kumar A; Singh PK; Zhang K; Kumar A
    FASEB J; 2020 Oct; 34(10):13826-13838. PubMed ID: 32813318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of mucoviscosity-associated gene A (magA) to virulence in experimental Klebsiella pneumoniae endophthalmitis.
    Hunt JJ; Wang JT; Callegan MC
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6860-6. PubMed ID: 21791595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of gram-positive bacterial endophthalmitis.
    Callegan MC; Booth MC; Jett BD; Gilmore MS
    Infect Immun; 1999 Jul; 67(7):3348-56. PubMed ID: 10377112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence-related genotypic differences among
    Coburn PS; Miller FC; LaGrow AL; Mursalin H; Gregory A; Parrott A; Astley D; Callegan MC
    Front Cell Infect Microbiol; 2023; 13():1304677. PubMed ID: 38106476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal Endophthalmitis.
    Talreja D; Singh PK; Kumar A
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1719-32. PubMed ID: 25678692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cereus matter of Bacillus endophthalmitis.
    Mursalin MH; Livingston ET; Callegan MC
    Exp Eye Res; 2020 Apr; 193():107959. PubMed ID: 32032628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute postoperative Bacillus cereus endophthalmitis mimicking toxic anterior segment syndrome.
    Rishi E; Rishi P; Sengupta S; Jambulingam M; Madhavan HN; Gopal L; Therese KL
    Ophthalmology; 2013 Jan; 120(1):181-5. PubMed ID: 22986113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis.
    Mursalin MH; Livingston E; Coburn PS; Miller FC; Astley R; Callegan MC
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis.
    Wiskur BJ; Hunt JJ; Callegan MC
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4931-8. PubMed ID: 18586871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence.
    Callegan MC; Kane ST; Cochran DC; Gilmore MS; Gominet M; Lereclus D
    Infect Immun; 2003 Jun; 71(6):3116-24. PubMed ID: 12761089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of secreted proteases to the pathogenesis of postoperative Enterococcus faecalis endophthalmitis.
    Suzuki T; Wada T; Kozai S; Ike Y; Gilmore MS; Ohashi Y
    J Cataract Refract Surg; 2008 Oct; 34(10):1776-84. PubMed ID: 18812133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.